In nonalcoholic fatty liver disease, hepatic steatosis and inflammation led to reduced FGF21 levels due to NF-κB-mediated Fgf21 transcription or interaction with SREBP1c with FGF21 [281]. Here, FGF21 is linked to Hepatic steatosis.